Gene · 4929
Papers4,115
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,115
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effector program of human CD8 T cells supports tissue remodeling. | J Exp Med | 2024 | 38226976 | PubTator, text mining | PubMed |
| Secretome Analyses Identify FKBP4 as a GBA1-Associated Protein in CSF and iPS Cells from Parkinson's Disease Patients with GBA1 Mutations. | Int J Mol Sci | 2024 | 38203854 | PubTator, text mining | PubMed |
| Characteristics of the synovial microenvironment and synovial mesenchymal stem cells with hip osteoarthritis of different bone morphologies. | Arthritis Res Ther | 2024 | 38200556 | PubTator, text mining | PubMed |
| Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson's disease model. | Nat Commun | 2024 | 38200091 | PubTator, text mining | PubMed |
| Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson's disease. | Sci Adv | 2024 | 38198537 | PubTator, text mining | PubMed |
| Gene architecture is a determinant of the transcriptional response to bulky DNA damages. | Life Sci Alliance | 2024 | 38167611 | PubTator, text mining | PubMed |
| Natural products and synthetic analogs as selective orphan nuclear receptor 4A (NR4A) modulators. | Histol Histopathol | 2024 | 38116863 | PubTator, text mining | PubMed |
| The nuclear receptor Nurr1 is preferentially expressed in human pro-inflammatory macrophages and limits their inflammatory profile. | Int Immunol | 2024 | 38066638 | PubTator, text mining | PubMed |
| Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosis. | Brain | 2024 | 38038362 | PubTator, text mining | PubMed |
| Human Motor System-Based Biohybrid Robot-On-a-Chip for Drug Evaluation of Neurodegenerative Disease. | Adv Sci (Weinh) | 2024 | 38036423 | PubTator, text mining | PubMed |
| Cellular development and evolution of the mammalian cerebellum. | Nature | 2024 | 38029793 | PubTator, text mining | PubMed |
| Inflammation as common link to progressive neurological diseases. | Arch Toxicol | 2024 | 37964100 | PubTator, text mining | PubMed |
| Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons. | Neural Regen Res | 2024 | 37843228 | PubTator, text mining | PubMed |
| Multifunctional glycolipids as multi-targeting therapeutics for neural regeneration. | Neural Regen Res | 2024 | 37843195 | PubTator, text mining | PubMed |
| Conserved islands of divergence associated with adaptive variation in sockeye salmon are maintained by multiple mechanisms. | Mol Ecol | 2024 | 37695544 | PubTator, text mining | PubMed |
| A role of NR4A2 in Graves' disease: regulation of Th17/Treg. | Endocrine | 2024 | 37651006 | PubTator, text mining | PubMed |
One-step cell biomanufacturing platform: porous gelatin microcarrier beads promote human embryonic stem cell-derived midbrain dopaminergic progenitor cell differentiation in vitro and survival after transplantation in vivo. | Neural Regen Res | 2024 | 37488911 | PubTator, text mining | PubMed |
| DNA methylation clocks for clawed frogs reveal evolutionary conservation of epigenetic aging. | Geroscience | 2024 | 37270437 | PubTator, text mining | PubMed |
| Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy. | Life Med | 2023 | 39872303 | PubTator, text mining | PubMed |
| Transcription factor-target gene regulatory network analysis in human lung adenocarcinoma. | J Thorac Dis | 2023 | 38249888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4929/papers?page=12